Rubric Capital Management LP - 31 Dec 2025 SCHEDULE 13G/A Report for Arcutis Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (ARQT)

Filing Manager
Rubric Capital Management LP
Reporting Manager
Rubric Capital Management LP
Security
Arcutis Biotherapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
ARQT
Shares outstanding
122,541,881 shares
Disclosed Ownership
8,271,577 shares
Ownership
6.8%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2026, 16:08:56 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Rubric Capital Management LP disclosed 6.8% ownership in Arcutis Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (ARQT) on 31 Dec 2025."

Quick Takeaways

  • Rubric Capital Management LP filed SCHEDULE 13G/A for Arcutis Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (ARQT).
  • Disclosed ownership: 6.8%.
  • Date of event: 31 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 13 Feb 2026, 16:08.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Rubric Capital Management LP 6.8% 8,271,577 0 8,271,577 /s/ Michael Nachmani Michael Nachmani / Chief Operating Officer
David Rosen 6.8% 8,271,577 0 8,271,577 /s/ David Rosen David Rosen / Individually

Sponsored